Dr. Given is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4048 Dressler Rd Nw
Suite 100
Canton, OH 44718Phone+1 330-479-3333Fax+1 330-479-3334
Summary
- Board Certified Allergy/Immunology and Pulmonary Medicine and Sleep Medicine in Chicago; University of Massachusetts Medical School MD degree 1978; years in practice: 38; Special interests: Mucus clearance and nocturnal GERD in management of COVID, asthma and COPD
Education & Training
- National Capital ConsortiumFellowship, Allergy and Immunology, 1984 - 1984
- Clinical Center at the National Institutes of HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1982 - 1984
- Brown UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 1981 - 1982
- Brown UniversityResidency, Internal Medicine, 1978 - 1981
- University of Massachusetts Medical SchoolClass of 1978
Certifications & Licensure
- IL State Medical License 2017 - 2026
- OH State Medical License 1984 - 2025
- MN State Medical License 2023 - 2023
- WI State Medical License 2023 - 2023
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
- American Board of Internal Medicine Sleep Medicine
Publications & Presentations
PubMed
- 9 citationsForced Expiratory Flow (FEF25-75%) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis.Stanley J. Szefler, Stanley Goldstein, Christian Vogelberg, George W Bensch, John Given
Pulmonary Therapy. 2020-05-12 - 10 citationsProspective, open-label evaluation of a new albuterol multidose dry powder inhaler with integrated dose counter.John T. Given, Herminia Taveras, Harald Iverson
Allergy and Asthma Proceedings. 2016-01-29 - 10 citationsProspective, open-label assessment of albuterol sulfate hydrofluoroalkane metered-dose inhaler with new integrated dose counter.John T. Given, Herminia Taveras, Harald Iverson, Mark S. Lepore
Allergy and Asthma Proceedings. 2013-01-01
Professional Memberships
- ChestMember
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: